These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Corpus luteum function in lactating women using the Progestasert system. Author: Abdalla MI, Ibrahim II, Osman MI, Badraoui MH, Askalani H. Journal: Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864. Abstract: Serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), and progesterone (P) were determined in lactating and menstruating women, 6-8 months after delivery. The subjects were categorized into 3 groups: non-IUD users, copper T-200 (Cu T 200) users, and Progestasert system users. Both types of IUDs were inserted immediately postpartum. When the values of each hormone determined at days M -4 and M -3 were averaged for each subject, remarkable decreases in the grand mean values of FSH, LH, and P were evident in Progestasert users. However, a significant difference was noted between the non-IUD and Progestasert groups for LH only. Considering serum P level as the index of corpus luteum function, the incidence of ovulation, corpus luteum insufficiency and anovulation was 50%, 17%, and 33%, respectively, in the Cu T 200 group; and 17, 33, and 50%, respectively, in the Progestasert group. Similar hormonal determinations were carried out 2 months postpartum in 2 groups of amenorrheic and lactating females fitted with Cu T 200 or Progestasert IUDs immediately after delivery. Results revealed 100% anovulation in the Progestasert group, whereas in the Cu T 200 amenorrheic group, 19, 9, and 72% were ovulating, poor corpus luteum, and anovulating, respectively. These data provide evidence that the Progestasert IUD exerts systemic depressive effect on the hypothalamic-pituitary-ovarian axis in lactating women.[Abstract] [Full Text] [Related] [New Search]